Diag2Tec – Preclinical CRO in Multiple Myeloma, Lymphoma, Leukemia
  • Home
  • Our Expertise
    • Multiple Myeloma
    • Hematological Cancer Cell Lines from Patients
    • Primary Samples from Hematological Malignancies
    • In Vitro Model of Human Plasma Cell Differentiation
    • Flow Cytometry
    • NGS – Biomarkers – New Therapeutic Targets Identification
  • Preclinical Services
    • In vitro Drug Testing
    • Immunotherapies : Assays and Analyses
    • Prognosis and Predictive Biomarkers
  • About us
    • Team & History
    • Prospects and Partners
    • ISO 9001: 2015 Certification
  • Press & Events
    • List of Publications and Patents
    • Meet our team
  • Contact
    • Contact us
    • Opportunities
logo

Interview of Jerome Moreaux, Diag2Tec’s CSO

Home → News → Interview of Jerome Moreaux, Diag2Tec’s CSO

By admin on November 4, 2015   /   News  
 Previous Post
Diag2Tec soutenue par Crealia
Next Post  
Diag2Tec visit in Florida

Diag2Tec’s Headquarters

Immeuble le Stratège
1095 rue Henri Becquerel
34000 Montpellier FRANCE

Diag2Tec’s Laboratories

CHU St Eloi, Dpt Hematology Biology
80 Av Augustin Fliche
34295 Montpellier FRANCE
Diag2Tec logo

  Contact us

Documentation

Services brochure
Publications and Patents
ISO 9001 Certification

Preclinical Services

In vitro Drug Testing
Immunotherapies : Assays and Analysis
Prognosis and Predictive Biomarkers
© Diag2Tec all rights reserved - Legal Notice
Back to Top